Many patients have begun to undergo genetic testing for age-related macular degeneration (AMD) to get a better understanding of their risk profile and possible advice on preventative measures they can take. But what exactly does the research show about the genetics of AMD, and what does genetic testing actually look for? And perhaps most importantly, how, if at all, does an understanding of one’s genetic propensity for AMD, ultimately affect treatment? Dr. Brian Ballios joins the podcast.